Primary culture of Helicobacter pylori from endoscopic gastric biopsies

Authors

DOI:

https://doi.org/10.51481/amc.v64i2.1180

Keywords:

gastric atrophy, gastric cancer, bacteriology, diagnostics

Abstract

Aim: To document the recent experiences on the implementation of sampling and culturing Helicobacter pylori in Costa Rica, to compare it with other diagnostic methods: rapid urease test and histopathology and to describe the diagnoses associated with the obtained isolates.
Methods: Descriptive research involving patients who visited the digestive endoscopy department of the Clínica Bíblica hospital in San José, Costa Rica between February and July of 2019 for gastroscopy. Gastric biopsies were obtained and histopathological analysis, rapid urease test, and bacteriological culture for Helicobacter pylori were performed. For culture techniques, the sample was transported in an in-house semi-solid medium. Biopsy fragments were macerated and plated on Skirrow agar and Helicobacter-selective in-house agar, and incubated in microaerophilic atmosphere for 48 hours to 10 days. Culture positivity was determined by observation of the colonial morphology and microscopic observation; Gram staining and biochemical tests (urease, catalase, and oxidase) were used for bacterial identification.
Results: 44 patients (mean aged 50.6 ± 10.0 years old, 54.5% male) were included in the study. Helicobacter pylori was recovered in biopsies from 27 patients (61.4% success rate). Bacterial growth was similar regardless the culture medium, but the physiological state of the bacteria was better in the Helicobacter-selective agar than in Skirrow. The weekly recovery rate increased to reach a 100% recovery plateau on week 11. Culture was compared with the rapid urease test in 27 patients, and the concordance between both methods using Cohen's kappa coefficient was 0.48. Whilst the culture detected Helicobacter pylori in 56% of the patients, and the rapid urease test in 37%, the combination of both allowed a 60% rate. The most frequent endoscopic diagnosis in patients with positive cultures were erythematous gastritis and chronic superficial gastritis, and the predominant histopathological diagnosis was chronic atrophic gastritis. Culture-based diagnosis was consistent with the histopathology detection of Helicobacter pylori in 80.4% of the cases.
Conclusions: The implementation of H. pylori culture in Costa Rica is possible. This study had a 61.4% recovery rate. The combination of culture with rapid urease test and histopathology increases the probability of an accurate and timely diagnosis. We recommend that, based on previously described protocols such as ours, each laboratory adjusts the conditions to allow a good recovery rate and implement H. pylori diagnostic methods most suitable to their routine activities.

Downloads

Download data is not yet available.

Author Biographies

  • Silvia Molina-Castro, Universidad de Costa Rica

    Universidad de Costa Rica, Programa de Epidemiología de Cáncer, Instituto de Investigaciones en Salud; Escuela de Medicina, Departamento de Bioquímica

  • Christian Campos-Núñez, Caja Costarricense de Seguro Social, Hospital San Francisco de Asís

    Caja Costarricense de Seguro Social, Hospital San Francisco de Asís, Servicio de Gastroenterología; Hospital Clínica Bíblica, Centro Integrado del Aparato Digestivo. Grecia

  • Vanessa Ramírez-Mayorga, Universidad de Costa Rica

    Universidad de Costa Rica, Programa de Epidemiología de Cáncer, Instituto de Investigaciones en Salud; Escuela de Nutrición, Sección de Nutrición Pública

References

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149. DOI:10.1002/ijc.33588.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023-75. DOI: 10.1016/s0140-6736(17)33326-3.

Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol. 2014;28:1055-68. DOI: 10.1016/j.bpg.2014.09.007.

Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9. DOI: 10.1111/j.1751-2980.2011.00550.x.

González CA, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell EJ, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol. 2012;23:1320-4. DOI: 10.1093/annonc/mdr384.

Megraud F, Bessede E, Varon C. Helicobacter pylori infection and gastric carcinoma. Clin Microbiol Infect. 2015;21:984-90. DOI: 10.1016/j.cmi.2015.06.004.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. DOI: 10.1136/gutjnl-2016-312288.

Dixon MF, Genta RM, Yardley JH, Correa P, The participants in the International Workshop on the Histopathology of Gastritis H. Classification and Grading of Gastritis: The Updated Sydney System. Am J Surg Pathol. 1996;20. DOI: 10.1097/00000478-199610000-00001.

Crafa P, Russo M, Miraglia C, Barchi A, Moccia F, Nouvenne A, et al. From Sidney to OLGA: an overview of atrophic gastritis. Acta Biomed. 2018;89:93-9. DOI: 10.23750/abm.v89i8-S.7946.

Skirrow MB. Campylobacter enteritis: a ""new"" disease. Br Med J. 1977;2:9-11. DOI: 10.1136/bmj.2.6078.9.

Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20:280-322. DOI: 10.1128/CMR.00033-06.

Sierra R, Muñoz N, Peña AS, Biemond I, van Duijn W, Lamers CB, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev. 1992;1:449-54.

Miranda M, Chaves M, San Román M, Durán S, Vargas G, Jiménez E, et al. La relación de Helicobacter pylori con la displasia y el cáncer gástrico en Costa Rica. Rev Biol Trop. 1998;46:829-32. DOI: 10.15517/RBT.V46I3.20473

Blanco-Delgado CA, Rivera P, Hernández F, Hevia F, Guillén F, Durán S, et al. Prevalencia de Helicobacter pylori en pacientes atendidos en el Hospital San Juan de Dios, San José, Costa Rica. Rev Biomed. 2001;12:1-4.

Con SA, Valerín AL, Takeuchi H, Con-Wong R, Con-Chin VG, Con-Chin GR, et al. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions. J Gastroenterol. 2006;41:632-7. DOI: 10.1007/s00535-006-1812-3.

Cornely EC, Forné M, Quintana S. Comparison of two transport media and three culture media for primary isolation of Helicobacter pylori from gastric biopsies. Clin Microbiol Infect. 2002;8:609-10. DOI: 10.1046/j.1469-0691.2002.00454.x.

Cellini L, Di Campli E, Di Bartolomeo S, Bessa LJ, Baffoni M, Di Giulio M. New transport medium for cultural recovery of Helicobacter pylori. J Clin Microbiol. 2014;52:4325. DOI: 10.1128/JCM.02850-14.

Martínez MJF, Rincón MR, De Castro AMB, Sánchez EG, Sánchez JEG, Martín IT, et al. Comparative evaluation of selective and nonselective media for primary isolation of Helicobacter pylori from gastric biopsies. Helicobacter. 1997;2(1):36-9. DOI: 10.1111/j.1523-5378.1997.tb00055.x.

Cover TL. Perspectives on methodology for in vitro culture of Helicobacter pylori. Methods Mol Biol. 2012;921:11-5. DOI: 10.1007/978-1-62703-005-2_3.

Perez-Perez GI, Van TN, Thu Huong D, Zhan G, Nguyet Anh D, Nguyet NT, et al. Isolation and characterization of Helicobacter pylori recovered from gastric biopsies under anaerobic conditions. Diagn Microbiol Infect Dis. 2016;86:136-40. DOI: 10.1016/j.diagmicrobio.2016.07.009.

Houghton J, Ramamoorthy R, Pandya H, Dhirmalani R, Kim KH. Human plasma is directly bacteriocidal against Helicobacter pylori in vitro, potentially explaining the decreased detection of Helicobacter pylori during acute upper GI bleeding. Gastrointest Endosc. 2002;55:11-6. DOI: 10.1067/mge.2002.120391.

Schilling D, Demel A, Adamek HE, Nüsse T, Weidmann E, Riemann JF. A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding: A prospective case control study. Dig Liv Dis. 2003;35:217-21. DOI: 10.1016/S1590-8658(03)00058-6.

Bermejo F, Boixeda D, Gisbert JP, Defarges V, Sanz JM, Redondo C, Martiní de Argila C, et al. Rapid urease test utility for Helicobacter pylori infection diagnosis in gastric ulcer disease. Hepatogastroenterology. 2002;49:572-5.

Castellote J, Guardiola J, Porta F, Falcó A. Rapid urease test: Effect of preimmersion of biopsy forceps in formalin. Gastrointest Endosc. 2001;53:744-6. DOI: 10.1067/mge.2001.114786.

Ozaslan E, Koseoglu T, Purnak T, Yildiz A. A forgotten cause of false negative rapid urease test: formalin contamination of the sample. Hepatogastroenterol. 2010;57.

Uotani T, Graham DY. Diagnosis of Helicobacter pylori using the rapid urease test. Ann Transl Med. 2014;3:9. DOI: 10.3978/j.issn.2305-5839.2014.12.04

Published

2022-04-01

How to Cite

Primary culture of Helicobacter pylori from endoscopic gastric biopsies. (2022). Acta Médica Costarricense , 64(2), 1-9. https://doi.org/10.51481/amc.v64i2.1180